EA201692284A1 - Ниацинамид для стимуляции продуцирования антимикробных пептидов - Google Patents

Ниацинамид для стимуляции продуцирования антимикробных пептидов

Info

Publication number
EA201692284A1
EA201692284A1 EA201692284A EA201692284A EA201692284A1 EA 201692284 A1 EA201692284 A1 EA 201692284A1 EA 201692284 A EA201692284 A EA 201692284A EA 201692284 A EA201692284 A EA 201692284A EA 201692284 A1 EA201692284 A1 EA 201692284A1
Authority
EA
Eurasian Patent Office
Prior art keywords
niacinamide
production
antimicrobial peptides
stimulating
skin
Prior art date
Application number
EA201692284A
Other languages
English (en)
Other versions
EA031758B1 (ru
Inventor
Амитабха Маджумдар
Мрутхунджая Свами Матхапати
Бхарат Паланисами
Кумар Рамиа Сампатха
Джоти Кумар Тивари
Original Assignee
Юнилевер Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юнилевер Н.В. filed Critical Юнилевер Н.В.
Publication of EA201692284A1 publication Critical patent/EA201692284A1/ru
Publication of EA031758B1 publication Critical patent/EA031758B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Изобретение относится к новому применению ниацинамида для стимуляции продуцирования AMP (антимикробных пептидов) в коже. Изобретение может применяться для улучшения иммунитета кожи, волосистой части кожи головы и полости рта в отношении микроорганизмов.
EA201692284A 2014-05-12 2014-05-12 Ниацинамид для стимуляции продуцирования антимикробных пептидов EA031758B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2014/059590 WO2015172801A1 (en) 2014-05-12 2014-05-12 Niacinamide for inducing generation of antimicrobial peptides

Publications (2)

Publication Number Publication Date
EA201692284A1 true EA201692284A1 (ru) 2017-03-31
EA031758B1 EA031758B1 (ru) 2019-02-28

Family

ID=50771476

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201692284A EA031758B1 (ru) 2014-05-12 2014-05-12 Ниацинамид для стимуляции продуцирования антимикробных пептидов

Country Status (8)

Country Link
JP (1) JP6446065B2 (ru)
CN (2) CN106413680A (ru)
BR (1) BR112016024400A2 (ru)
EA (1) EA031758B1 (ru)
MX (1) MX2016014760A (ru)
PH (1) PH12016502047A1 (ru)
WO (1) WO2015172801A1 (ru)
ZA (1) ZA201607105B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118680840A (zh) 2015-08-10 2024-09-24 玫琳凯有限公司 局部用组合物
MX2018004143A (es) 2015-10-05 2018-06-13 Unilever Nv Composicion que comprende niacinamida y picolinamida.
JP6942725B2 (ja) * 2016-05-10 2021-09-29 ユニリーバー・ナームローゼ・ベンノートシヤープ 局所抗菌組成物
US10869862B2 (en) 2016-05-26 2020-12-22 Conopco, Inc. Antimicrobial compositions for topical use
WO2018218012A1 (en) * 2017-05-24 2018-11-29 Follea International Synephrine compositions
WO2019086327A1 (en) 2017-10-30 2019-05-09 Unilever N.V. Use of niacinamide for microbiome balancing
CN111491612B (zh) * 2017-12-18 2023-10-20 联合利华知识产权控股有限公司 局部组合物
CN111683649A (zh) * 2017-12-18 2020-09-18 荷兰联合利华有限公司 基于烟酰胺衍生物的局部组合物
EP3764975B1 (en) 2018-03-13 2021-10-13 Unilever Global IP Limited A sanitizer composition
WO2024042554A1 (en) * 2022-08-25 2024-02-29 Istituto Fondazione Di Oncologia Molecolare Ets A pharmaceutical composition for treatment of viral infections
WO2024041910A1 (en) * 2022-08-25 2024-02-29 Unilever Ip Holdings B.V. Inactivation or kill of virus and compositions thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN892496A0 (en) * 1996-03-25 1996-04-18 Technical Consultancy Services Pty Limited Acne treatment
US7026308B1 (en) * 1999-06-25 2006-04-11 The Procter & Gamble Company Topical anti-microbial compositions
AU2005293830B2 (en) * 2004-10-15 2010-10-21 Bayer Consumer Care Ag Acidic and buffered skin-care compositions comprising nicotinamid and an absorbing agent
CN101019865A (zh) * 2007-01-23 2007-08-22 中国医学科学院皮肤病医院 抗炎、保湿、祛斑的复方烟酰胺药用组合物
WO2011133692A1 (en) * 2010-04-20 2011-10-27 Cedars-Sinai Medical Center Boosting immune defense by upregulating ccaat/enhancer binding protein epsilon
WO2012049677A2 (en) * 2010-10-10 2012-04-19 Dermipsor Ltd. Compositions for treating psoriasis of the scalp
FR2973699B1 (fr) * 2011-04-05 2013-04-26 Oreal Nouvel actif apte a induire au stimuler la production de peptides anti microbiens dans le cuir chevelu, utile pour prevenir et/ou traiter les etats pelliculaires du cuir chevelu
US8293790B2 (en) * 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
DE102012002592A1 (de) * 2012-02-13 2013-08-14 Dr. Kurt Wolff Gmbh & Co. Kg Verwendung eines Mittels zur Stimulation der Gen-Expression antimikrobieller Peptide (AMP)
EP2861229B1 (en) * 2012-06-15 2020-12-23 CONARIS research institute AG A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota
EP3120850B1 (en) * 2012-12-14 2018-11-07 Unilever N.V. Niacinamide for inducing generation of antimicrobial peptides

Also Published As

Publication number Publication date
EA031758B1 (ru) 2019-02-28
MX2016014760A (es) 2017-03-06
CN106413680A (zh) 2017-02-15
JP6446065B2 (ja) 2018-12-26
CN113908074A (zh) 2022-01-11
BR112016024400A2 (pt) 2017-08-15
ZA201607105B (en) 2018-05-30
PH12016502047A1 (en) 2017-01-09
JP2017515829A (ja) 2017-06-15
WO2015172801A1 (en) 2015-11-19

Similar Documents

Publication Publication Date Title
EA201692284A1 (ru) Ниацинамид для стимуляции продуцирования антимикробных пептидов
JOP20200192A1 (ar) أجسام مضادة لـ tigit
CY1123065T1 (el) Ανασυνδυασμενα προβιοτικα βακτηριδια
TWD170518S (zh) 美容器具
EA201790273A1 (ru) Флагеллиновые композиции и их применение
CA160630S (en) Body groomer
CA163246S (en) Handle for toothbrush
EA201692529A1 (ru) Способы и композиции для лечения расстройств с использованием фоллистатиновых полипептидов
EA201692254A1 (ru) Иммуномодулирующие прогениторные (имп) клетки
MX2017000306A (es) Metodos para tratar hipotension.
MX2017005975A (es) Anticuerpos anti factor de crecimiento derivado de plaquetas b (pdgf-b) y metodos de uso.
MX2017006019A (es) Apilimod para uso en el tratamiento de melanoma.
NZ745186A (en) 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
PH12018502161A1 (en) Methods of treatment for cholestatic and fibrotic diseases
EA202190281A1 (ru) Производные 3-((гетеро-)арил)-8-амино-2-оксо-1,3-диаза-спиро[4,5]декана
EP3549582A3 (en) Novel capsazepine analogs for the treatment of cancer and other proliferative diseases
ZA201608607B (en) Novel fluoroquinolones and use thereof to treat bacterial infections
EA201590615A1 (ru) Стимулирующие лактацию композиции на основе фосфатидилсерина
GEP20207145B (en) Combination of trazodone and gabapentin for the treatmen
SG10201903630UA (en) Iminosugars useful for the treatment of viral diseases
CY1119212T1 (el) Χρηση του odiparcil στη θεραπεια μιας μυκοπολυσακχαριδωσης
PH12016501179B1 (en) Composition
PH12018500339A1 (en) Lysobactin for use in the treatment of bovine mastitis
MX2018011250A (es) Kit para el tratamiento cosmetico del ojo y de la piel y cosmetico para la aplicacion en el ojo y sobre la piel.
UA100460U (uk) Застосування препарату ноофен як засобу лікування еректильної дисфункції в моно- або комплексній терапії

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM

PC4A Registration of transfer of a eurasian patent by assignment